Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides

Brad A. Hartl, David L. Boucher, Laura Marcu, Simon R Cherry

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Cerenkov luminescence generated from radionuclides was used as a novel light source for photodynamic therapy. This technique, in conjunction with administration of δ-aminolevulinic acid, was shown to inhibit growth of U-87 glioblastoma cells in vitro. Optics in the Life Sciences Congress Technical Digest

Original languageEnglish (US)
Title of host publicationBio-Optics: Design and Application, BODA 2013
StatePublished - 2013
EventBio-Optics: Design and Application, BODA 2013 - Waikoloa Beach, HI, United States
Duration: Apr 14 2013Apr 18 2013

Other

OtherBio-Optics: Design and Application, BODA 2013
CountryUnited States
CityWaikoloa Beach, HI
Period4/14/134/18/13

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Atomic and Molecular Physics, and Optics

Fingerprint Dive into the research topics of 'Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides'. Together they form a unique fingerprint.

  • Cite this

    Hartl, B. A., Boucher, D. L., Marcu, L., & Cherry, S. R. (2013). Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides. In Bio-Optics: Design and Application, BODA 2013